Table 1.
Characteristics of included studies
References | Year | Location | Study design | No. patients | Male, n (%) | Study population | CIN incidence% |
---|---|---|---|---|---|---|---|
Yildirim et al.19 | 2019 | Turkey | Retrospective cohort | 200 | 124 (62) | Patients With ACS undergoing emergency CAG | 19.1 |
Oksuz et al.20 | 2015 | Turkey | Retrospective cohort | 473 | 367 (78) | Patients With STMI undergoing p-PCI | 16.91 |
Aksoy et al.21 | 2020 | Turkey | Prospective cohort | 300 | 243 (81) | Patients With STMI undergoing p-PCI | 16.7 |
Toporak22 | 2022 | Turkey | Retrospective cohort | 373 | 227 (60.8) | Patients With NSTEMI undergoing CAG | 27 |
ACS, acute coronary syndrome; CAG, coronary angiogram; CIN, contrast-induced nephropathy; NSTEMI, non-ST-elevation myocardial infarction; p-PCI, primary percutaneous coronary intervention; STMI, ST elevation myocardial infarction.